House Committee Summons Former Pfizer Executive
House Attorney General Jim Jordan has called Dr. Philip Domitzer to testify regarding the investigation into the delay of the COVID-19 vaccine in 2020. Domitzer, who previously held a key position as Pfizer’s global vaccine research and development director, declined to appear before the House Judiciary Committee through his attorney, Susan Brune.
Brune informed the committee of Domitzer’s refusal on May 29. However, Jordan formally summoned him, and he is expected to present himself before the committee on July 22 at 10am.
In a press release, Jordan stated, “The claims that certain Pfizer employees conspired to withhold vital public health information to influence the 2020 presidential election raise significant federal concerns that need further investigation, potentially leading to legislative changes.”
In another update, Brune narrowed the committee’s request for documents, asserting that Domitzer had no relevant documents to offer. However, Jordan contested that point, highlighting that Brune’s response did not sufficiently cover the four categories that were requested.
The committee noted in a letter from May 15 that it had received evidence indicating Domitzer had contacted senior law enforcement officials at GSK multiple times during mid-November 2020. There are allegations that Pfizer’s top research and development officials are linked to the delay in clinical trials to ensure that results were not released prior to the presidential election.
Additionally, the committee was informed that while it had obtained insights regarding specific communications, Brune’s replies did not adequately refute claims made by GSK about intentional delays in disclosing results related to the vaccine.
Jordan emphasized in another letter that Domitzer’s testimony is crucial for the committee’s oversight, arguing that Brune’s response did not explain his failure to comply with their initial requests.
In light of these developments, Jordan reiterated that as long as Pfizer has provided information, it does not absolve Domitzer from fulfilling his obligation to comply with the subpoena issued by the committee.
On May 15, prior to this, Jordan had sent letters to both Domitzer and Pfizer CEO Dr. Albert Bourla. The letters sought testimony concerning claims that the announcement of the vaccine’s efficacy was delayed until just after the 2020 election, which some believe was to hinder Trump’s re-election campaign.
